BioDlink Modernizes Quality Management with Successful Go-Live of Veeva QMS
BioDlink has successfully implemented Veeva QMS, marking a key milestone in its digital transformation and strengthening its GMP quality management capabilities. It enables a standardized, data-driven quality framework, supporting compliance, efficiency, and long-term continuous improvement for global partners. SUZHOU, China, Feb. 3, 2026 /PRNewswire/ -- BioDlink today announced the successful...
Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy. NEWARK, Del. and NANJING, China, Feb. 3, 2026 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a...
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases. Under the agreement, Vertex will have...
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostics and vaccines for malaria, tuberculosis (TB), and neglected tropical diseases (NTDs).2 Investment of JPY 648 million (approx. USD 4.1 million1) for development of an...
21 Asian Countries Among 93 Worldwide at Risk of Losing Nearly 23 Million More People by 2030
ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts in 93 countries, with 21 in Asia New study published in The Lancet finds slashing global aid, particularly by US and European countries, will reverse decades of progress in fighting diseases BANGKOK, Feb. 3, 2026 /PRNewswire/ -- The Lancet Global Health published a new peer-reviewed study...
ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency, precision, and surgical safety. JENA, Germany and SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750...
ACROBiosystems Powers Innovation at bioSeedin’s JPM Spotlight, Strategically Supporting Global Partnership Forging
SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a key strategic partner, joined hands with multiple enterprises to participate in the event. Hosted by bioSeedin and centered on the theme "Global Matching of...
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE...
3Shape TRIOS 6 intraoral scanner wins the European Product Design Award (EPDA) 2025
COPENHAGEN, Denmark, Feb. 2, 2026 /PRNewswire/ -- 3Shape today announced that the TRIOS 6 intraoral scanner has been honored with the European Product Design Award (EPDA) 2025 in the category Industrial/Healthcare: Medical Products. The EPDA Award Statement: "TRIOS 6 combines cutting-edge functionality with meticulous Danish design. Its sleek, pen-grip form reflects the precision of its advanced technology while ensuring effortless...
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech
- SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million upfront payment and will be eligible to receive development and commercialization milestone payments, totaling up to $1.5 billion, plus tiered royalties - Genentech will be responsible for the subsequent clinical development and commercialization globally BOSTON, SHANGHAI and SUZHOU, China,...
